Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.

@article{Heide2009SerumTA,
  title={Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.},
  author={Rogier Heide and Karen Van Doorn and P. G. Mulder and Albert W van Toorenenbergen and Auke Beishuizen and Hans G. W. de Groot and Bhupendra Tank and Arnold Pieter Oranje},
  journal={Clinical and experimental dermatology},
  year={2009},
  volume={34 4},
  pages={462-8}
}
BACKGROUND Skin lesions are the predominant clinical feature of the commonest form of mastocytosis. Mastocytosis is classified according to World Health Organization criteria. Determination of the levels of mast-cell mediators or their metabolites reflects the mast-cell burden. The extent of cutaneous mastocytosis can be assessed clinically using a scoring system (SCORing MAstocytosis; SCORMA Index) that we have developed. OBJECTIVE Serum tryptase levels were compared with the SCORMA Index in… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Mastocytosis : state of the art

  • K Hartmann, BM Henz
  • Pathobiology
  • 2007

Mastocytosis. In: Textbook of Pediatric Dermatology (Harper JI

  • D van Gysel, R van Schaik, AP. Oranje
  • Oranje AP, Prose NP). Oxford: Blackwell Science,
  • 2006

Assessment of the extent of cutaneous involvement in children and adults with mastocytosis : relationship to symptomatology , tryp - tase levels , and bone marrow pathology

  • HJ Droogendijk, HJ Kluin-Nelemans, JJ vanDoormaal
  • 2003

Similar Papers

Loading similar papers…